A Randomized Controlled Trial on Twagadi Leha with Vyaghri Haritaki in the Management of Kaphaja Kasa with special reference to Chronic Bronchitis. - Nil

Dr Mayuri Shingnapurkar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1. Patients of either sex aged between 18 to 60 years.
•2. Patients having any of following two or more signs and symptoms of Kaphaja Kasa described in the text –
•Kasa (cough), Anga Gaurava, Shirogaurava, Shirashoola (Headache), Kaphasampoorna ura, Nishtheevan (Sputum) & Aruchi (Anorexia).
•3. Patient with history of uncomplicated Chronic Bronchitis.
•4. Patients having PEFR = 50% of the predicted value.
•5. Patients willing and able to participate in the study for 12 weeks.

•1. Patients suffering from Acute Bronchitis. 2. Patients having PEFR < 50% of the predicted value. 3. Patients suffering from other pulmonary diseases like Emphysema, Cor pulmonale, Cyanosis, Pneumonia, Cystic fibrosis and major systemic diseases like Rheumatoid arthritis,active Tuberculosis, Cardiac Disorders, CA Lung, AIDS etc. 4. Patients suffering from Diabetes Mellitus. 5. Patients with uncontrolled Hypertension.( >160/100mm of hg) 6. Patients on medication with corticosteroids, bronchodilators, mast cell stabilizers, antidepressants, anti-cholinergic, etc. or any other drugs that may have an influence on the outcome of the study in last 30 days. 7. Patients with viral Hepatitis. 6. Tobacco eaters and/or smokers. 9. Pregnant or lactating women 10. Patients who are not willing to give informed consent.

发起方

Dr Mayuri Shingnapurkar